Terapiia diltiazemom i verapamilom u bol'nykh stenokardiei na fone arterial'noi gipotonii.

Translated title of the contribution: Diltiazem and verapamil therapy in patients with angina pectoris associated with arterial hypotension

E. M. Idrisova, T. A. Stepacheva, N. V. Borovkova, V. I. Chernov, R. S. Karpov, E. V. Vorob'eva, I. S. Poponina

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

A randomized blind cross-over study with placebo lead-in compared efficacy of calcium antagonists diltiazem and verapamil in 71 patients with stable angina concurrent with arterial hypotension (group 1) and 38 normotensive patients with ischemic heart disease (group 2). By acute bicycle exercise test evidence, verapamil was effective in 80% and 82% patients of group 1 and 2, respectively, dilitiazem--in 67 and 77%, respectively. Cumulation of the effect (p < 0.01) to the third month of verapamil course was comparable in both groups. Tolerance to an antianginal effect of dilitazem developed in 53% patients of group 1 (against 30% in group 2, p < 001) in 2-4 weeks of therapy (against 4-12 weeks in group 2, p < 0.05). By stress 199-T1 scintigraphy of the myocardium, administration of effective doses of diltiazem reduced the number of hypoperfused segments by at least 30%.

Translated title of the contributionDiltiazem and verapamil therapy in patients with angina pectoris associated with arterial hypotension
Original languageRussian
Pages (from-to)42-46
Number of pages5
JournalKlinicheskaia meditsina
Volume82
Issue number2
Publication statusPublished - 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Diltiazem and verapamil therapy in patients with angina pectoris associated with arterial hypotension'. Together they form a unique fingerprint.

Cite this